4.6 Letter

Allogeneic T-Cell Therapy for Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease: Long-Term Follow-Up

Journal

TRANSPLANTATION
Volume 90, Issue 1, Pages 93-94

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/TP.0b013e3181d7c424

Keywords

-

Funding

  1. Cancer Research UK [C307/A3869, SP 2278/0202] Funding Source: Medline
  2. Wellcome Trust [GR 086952] Funding Source: Medline

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available